Healthy Skepticism Library item: 2031
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Drug-company decision to end cancer trial.
Lancet 1999 Sep 25; 354:(9184):1045
http://linkinghub.elsevier.com/retrieve/pii/S0140673699003207
Keywords:
Publication Types:
Editorial
MeSH Terms:
Advisory Committees
Antidotes/therapeutic use
Antimetabolites, Antineoplastic/adverse effects*
Clinical Trials
Colonic Neoplasms/drug therapy*
Control Groups
Drug Industry
Europe
Fluorouracil/therapeutic use
Humans
Leucovorin/therapeutic use
Multicenter Studies
Quinazolines/adverse effects*
Research Subjects
Thiophenes/adverse effects*
Substances:
Antidotes
Antimetabolites, Antineoplastic
Quinazolines
Thiophenes
raltitrexed
Fluorouracil
Leucovorin
